Discovery Laboratories And Philip Morris Unit Ink Drug Deal

NEW YORK, Dec 12 (Reuters) - Discovery Laboratories Inc. (DSCO.O: Quote, Profile, Research) said on Monday it is forming an alliance with Chrysalis Technologies, a unit of tobacco company Philip Morris USA, to develop of drug-device systems for respiratory diseases.

MORE ON THIS TOPIC